JP2023535361A5 - - Google Patents
Info
- Publication number
- JP2023535361A5 JP2023535361A5 JP2023503101A JP2023503101A JP2023535361A5 JP 2023535361 A5 JP2023535361 A5 JP 2023535361A5 JP 2023503101 A JP2023503101 A JP 2023503101A JP 2023503101 A JP2023503101 A JP 2023503101A JP 2023535361 A5 JP2023535361 A5 JP 2023535361A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- crystalline form
- diffraction peaks
- xrpd pattern
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010737039 | 2020-07-28 | ||
| CN202010737039.7 | 2020-07-28 | ||
| PCT/CN2021/108032 WO2022022398A1 (zh) | 2020-07-28 | 2021-07-23 | 一种嘧啶类化合物的盐和晶型及其制备方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023535361A JP2023535361A (ja) | 2023-08-17 |
| JP2023535361A5 true JP2023535361A5 (https=) | 2024-07-29 |
| JP7688690B2 JP7688690B2 (ja) | 2025-06-04 |
Family
ID=80037147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023503101A Active JP7688690B2 (ja) | 2020-07-28 | 2021-07-23 | ピリミジン系化合物の塩、結晶形およびその調製方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230295174A1 (https=) |
| EP (1) | EP4190781A4 (https=) |
| JP (1) | JP7688690B2 (https=) |
| KR (1) | KR20230044358A (https=) |
| CN (1) | CN115702154A (https=) |
| BR (1) | BR112023000065A2 (https=) |
| WO (1) | WO2022022398A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120897743A (zh) * | 2023-05-19 | 2025-11-04 | 四川科伦博泰生物医药股份有限公司 | 杂环化合物治疗与ret基因改变相关疾病的用途和方法 |
| WO2026017002A1 (zh) * | 2024-07-16 | 2026-01-22 | 四川科伦博泰生物医药股份有限公司 | 以杂环化合物为活性成分的药物组合物、其制备方法及用途 |
| GB202410599D0 (en) | 2024-07-19 | 2024-09-04 | Ellipses Pharma Ltd | Therapeutics useful synergistic combinations |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008525422A (ja) * | 2004-12-23 | 2008-07-17 | ファイザー・プロダクツ・インク | 抗癌剤として有用な複素芳香族誘導体 |
| US20080234267A1 (en) * | 2007-03-20 | 2008-09-25 | Karen Elizabeth Lackey | Compounds and Methods of Treatment |
| BR112018000808A2 (pt) * | 2015-07-16 | 2018-09-04 | Array Biopharma Inc | compostos de pirazolo[1,5-a]piridina substituída como inibidores de ret cinase |
| WO2018136661A1 (en) * | 2017-01-18 | 2018-07-26 | Andrews Steven W | SUBSTITUTED PYRAZOLO[1,5-a]PYRAZINE COMPOUNDS AS RET KINASE INHIBITORS |
| WO2020114388A1 (zh) * | 2018-12-06 | 2020-06-11 | 深圳市塔吉瑞生物医药有限公司 | 取代的吡唑并[1,5-a]吡啶化合物及包含该化合物的组合物及其用途 |
| CN111285882B (zh) * | 2018-12-07 | 2022-12-02 | 四川科伦博泰生物医药股份有限公司 | 稠环化合物、包含其的药物组合物及其制备方法和用途 |
| JP7615056B2 (ja) * | 2019-02-19 | 2025-01-16 | スーチュアン・コールン－バイオテック・バイオファーマシューティカル・カンパニー・リミテッド | 複素環化合物、これを含む薬物組成物、その製造方法および使用 |
| KR20230159367A (ko) | 2021-03-24 | 2023-11-21 | 쓰촨 케룬-바이오테크 바이오파마수티컬 컴퍼니 리미티드 | 키나아제 약물 내성 돌연변이와 관련된 질병의 치료에있어서의 헤테로사이클릭 화합물의 용도 및 그 방법 |
-
2021
- 2021-07-23 WO PCT/CN2021/108032 patent/WO2022022398A1/zh not_active Ceased
- 2021-07-23 KR KR1020227041673A patent/KR20230044358A/ko active Pending
- 2021-07-23 EP EP21849031.6A patent/EP4190781A4/en active Pending
- 2021-07-23 CN CN202180038857.0A patent/CN115702154A/zh active Pending
- 2021-07-23 US US18/017,104 patent/US20230295174A1/en active Pending
- 2021-07-23 BR BR112023000065A patent/BR112023000065A2/pt unknown
- 2021-07-23 JP JP2023503101A patent/JP7688690B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023535361A5 (https=) | ||
| RU2490258C2 (ru) | ПРОИЗВОДНЫЕ ГИДРОБЕНЗАМИДА В КАЧЕСТВЕ ИНГИБИТОРОВ Hsp90 | |
| JP2024026550A5 (https=) | ||
| TW418198B (en) | Piperazine derivatives and pharmaceutical composition comparising the same | |
| JP2020511467A5 (https=) | ||
| JP2021530451A5 (https=) | ||
| JP2022049005A5 (https=) | ||
| JP2025504379A5 (https=) | ||
| JP2021524835A5 (https=) | ||
| JP2010501519A5 (https=) | ||
| JP2005528325A5 (https=) | ||
| CN115702154A (zh) | 一种嘧啶类化合物的盐和晶型及其制备方法 | |
| JP2022526438A5 (https=) | ||
| RU2015103065A (ru) | Кристаллическая форма i дималеата ингибитора тирозинкиназы и способ ее получения | |
| JP2020521732A5 (https=) | ||
| JP2008546640A5 (https=) | ||
| JP2022534788A5 (https=) | ||
| US20210130333A1 (en) | Crystal of benzofuran derivative free base and preparation method | |
| JP2024541533A5 (https=) | ||
| JP2016537326A5 (https=) | ||
| JP2024125139A5 (https=) | ||
| RU2483064C2 (ru) | Твердые формы ингибитора raf-киназы | |
| JP2009517353A5 (https=) | ||
| JP2018537486A5 (https=) | ||
| CN111989329A (zh) | 氘代3-(4,5-取代氨基嘧啶)苯基化合物单甲磺酸盐晶型及其制备方法 |